Factor VIII protein replacement therapy/gene therapy (Lapix Therapeutics)

N/A

Report date: 2026/01/27 10:13:55

Base Information

Drug NameFactor VIII protein replacement therapy/gene therapy (Lapix Therapeutics)
Drug Alias NameFactor VIII program (Lapix Therapeutics)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCoagulation factor VIII modulators
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLAPIX Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLAPIX Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A